Easom Eric 4
4 · AN2 Therapeutics, Inc. · Filed Nov 18, 2024
Insider Transaction Report
Form 4
Easom Eric
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2024-11-18$1.00/sh+50,000$49,970→ 1,065,766 total(indirect: See Footnote)
Holdings
- 101,130
Common Stock
- 97,058(indirect: See Footnote)
Common Stock
- 97,058(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019.
- [F2]Includes 99,000 restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2024, subject to the Reporting Person's continuous service as of each such date.
- [F3]Consists of shares of Common Stock held by the C Easom Irrevocable Trust dated October 8, 2021.
- [F4]Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.